Could a probiotic calm gut inflammation in overweight people?
NCT ID NCT07253155
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a probiotic called Streptococcus thermophilus (FX856) in 100 overweight or obese adults. The goal is to see if it can reduce mild gut inflammation and improve digestive symptoms. Participants will take the probiotic or a placebo in a crossover design, and researchers will measure inflammation markers and symptom scores.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Streptococcus thermophilus (FX856) probiotic
What this could lead to
If it works, this could point toward a simple probiotic supplement to reduce gut inflammation and improve digestive symptoms in people with overweight or obesity.
What could go wrong
This is a small early-stage trial with only 100 people, so results may not apply to everyone. The probiotic may not reduce inflammation or symptoms as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUT INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ulster University, Human Intervention Studies Unit
Coleraine, BT52 1SA, United Kingdom